Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve opioid-related claims against the drugmaker. Shares of the Pennsylvania-based company, formed by the merger of Mylan and Pfizer’s …
The U.S. Treasury Department is examining unilateral actions to curb corporate inversions, reversing its position that only Congress has the authority to stop or slow the deals. About three weeks after Secretary Jacob J. Lew said officials had scoured “obscure …
A federal appeals court on Friday upheld the dismissal of nearly all claims in 68 cases seeking to hold drug makers liable for injuries from the use of the prescription painkillers Darvon and Darvocet, which were pulled from the U.S. …
